In conditions such as asthma and allergic airway diseases, CIP2A may modulate immune responses by either directly influencing immune cells like T cells and macrophages or by altering upstream cytokine signaling pathways, which subsequently modulate their activity [67,68]. Here, CIP2A is linked to asthma.